In a new 2-stage assay of platelet procoagulant activity (PCA), we first subjected gel-filtered platelets to adhesion on collagen (as a model of primary hemostasis) or plasma clots (as a model of preformed thrombus) for 30 minutes, and then the adherent platelets were supplemented with pooled, reptilase-treated, diluted plasma. Defibrinated plasma provided coagulation factors for assembly on platelet membranes without uncontrolled binding of thrombin to fibrin(ogen). Platelet adhesion to both surfaces showed modest individual variation, which increased at platelet densities that allowed aggregation. However, adhesion-induced PCA varied individually and surface-independently Ͼ3-fold, suggesting a uniform platelet procoagulant mechanism. Permanently adhered platelets showed markedly enhanced PCA when compared with the platelet pool in suspension, even after strong activation. The rate of thrombin generation induced by clot-adherent platelets was markedly faster than on collagen-adherent platelets during the initial phase of coagulation, whereas collagen-induced PCA proceeded slowly, strongly promoted by tissue thromboplastin. Therefore at 10 minutes, after adjustment for adhered platelets, collagen supported soluble thrombin formation as much as 5 times that of the thrombin-retaining clots. Activation of platelets by their firm adhesion was accompanied by formation of microparticles, representing about one third of the total soluble PCA. Collagen-adhered platelets provide soluble thrombin and microparticles, whereas the preformed clot serves to localize and accelerate hemostasis at the injury site, with the contribution of retained thrombin and microparticles. (Arterioscler Thromb Vasc Biol. 2001;21:628-635.)
D uring hemostasis and thrombosis, primary platelet activation and aggregation and secondary clotting are recognized to interact, thereby amplifying each other. [1] [2] [3] [4] Activated platelets accelerate coagulation by exposing a procoagulant phospholipid surface 5 and factor V, 6 whereas thrombin, the enzymatic end product of coagulation, is considered the most potent activator of platelets. 7 This interplay establishes a powerful resonance loop, which localizes itself at the site of vessel injury.
The platelet surface also localizes the negative-feedback reactions of coagulation, such as inactivation of factors Va and VIIIa by activated protein C 8 and inactivation of activated protein C by protein C inhibitor. 9 Despite the important functional role of platelets in directing the coagulation system and its regulation at the site of injury, relatively little is known about the procoagulant activity (PCA) of adherent platelets on thrombogenic surfaces. 10 -13 These few kinetic studies have essentially used purified components, factors Va and Xa, instead of plasma or have been performed with plasma and platelets in suspension or in whole blood. In fact, the reports currently available do not directly concern PCA triggered in situ by firmly adhered platelets when supplemented with plasma. These considerations are validated by the fact that platelet adhesion and subsequent activation may significantly vary, depending on the adhesive receptors, their signaling abilities, and procoagulant capacity. Also, thrombin generation must overcome the natural anticoagulants to support hemostasis or thrombosis on the very same platelet phospholipid surfaces. 3 In addition to activated platelets, platelet-derived microvesicles provide the mandatory procoagulant phospholipids and lower the threshold at which activated clotting factors will induce explosive thrombin generation. 14 -17 The aim of this study therefore was to compare the PCA of platelets activated by permanent adhesion with that of platelets activated in suspension. Thus, we studied adhesioninduced PCA by using (1) collagen as an initial plateletadhesive surface and (2) a plasma fibrin clot as a preformed thrombus promoting sustained interaction between platelets and coagulation. Moreover, we assessed individual differences in adhesion-induced PCA, the role of the extrinsic pathway, and the contribution of adhesion-induced microparticles (MPs).
Methods

Blood Collection
The present study was approved by the institutional review board. Blood was obtained from healthy, nonsmoking volunteers who had not taken any medication during the previous 14 days. Free-flowing blood was collected by venipuncture of a cubital vein with use of a polytetrafluoroethylene cannula (BOC Ohmeda AB). The first 3 mL was collected in EDTA for blood cell counts by a Coulter T-540 Thrombocounter (Coulter Electronics, Inc). For gel-filtered platelets (GFPs), 6 volumes of blood were collected in 1 volume of 131 mmol/L acidic citrated dextrose (pH 4.5), and for plasma separation, 9 volumes of blood were collected into 1 volume of 110 mmol/L sodium citrate.
Pooled and Defibrinated Plasma
Pooled, citrated, platelet-poor plasma (PPP) was prepared by repeated centrifugation (1500g, 10 minutes, 22°C) and used as an adhesive substrate. Fibrinogen content was assessed by the functional method of Clauss (bovine ␣-thrombin; Dade, Baxter Healthcare Corp). Prothrombin fragment 1ϩ2 (F1ϩ2), thrombin-antithrombin III complex (TAT), and D-dimer levels were analyzed with the corresponding ELISAs (Enzygnost F1ϩ2 micro and TAT micro, Behring; and Asserachrom D-Di, Diagnostica Stago, respectively). Their values in pooled plasma were as follows: fibrinogen 3.1 mg/mL, F1ϩ2 0.9 nmol/L, TAT 3.8 ng/mL, and D-dimer 157 ng/mL. Also, activated partial thromboplastin time, thrombin time, and prothrombin time were within the normal ranges.
Pooled, defibrinated plasma was prepared essentially by the method of Hemker and coauthors 18 and used as the source of procoagulant and anticoagulant factors to avoid clot formation and uncontrolled binding of thrombin during the assay. 19, 20 One volume of reptilase (STA-Reptilase, 20 BU/mL, Diagnostica Stago) was added to 49 volumes of the plasma and incubated (5 minutes, 37°C, 10 minutes on ice). The clot was centrifuged (2100g, 4°C, 10 minutes) and plasma was separated. In this reptilase-treated plasma, F1ϩ2 was 1.1 nmol/L, TAT 4.3 ng/mL, and D-dimer Ͻ500 ng/mL (NycoCard D-Dimer, Nycomed Pharma AS). Ristocetin (1 mg/mL, Sigma Chemical Co) -induced aggregation of GFPs in defibrinated plasma indicated the presence of functional von Willebrand factor.
GFPs and Labeling With [ 3 H]Serotonin
GFPs were prepared from platelet-rich plasma (PRP) as previously reported. [21] [22] [23] In brief, platelets suspended in HEPES buffer without cations were eluted through a Sepharose CL-2B column (Pharmacia LKB Biotechnology Inc). To control platelet activation during filtration, small doses of apyrase (1 U/mL, Sigma) and prostaglandin E 1 (25 ng/mL, Sigma) were added to the PRP. Isolated platelets were diluted in HEPES buffer to different densities (10 to 300ϫ10 6 /mL), and 2 mmol/L CaCl 2 and 1 mmol/L MgCl 2 were added just before assay.
For adhesion studies, GFPs were incubated (15 minutes, 37°C) with [ 3 H]serotonin [5-hydroxy(G-3 H)tryptamine creatinine sulfate, Amersham International plc]. The final concentration of added [ 3 H]serotonin in GFPs (300ϫ10 6 platelets per mL) was 10 nmol/L. Labeling and quantification of deposited 3 H-positive platelets after their activation were performed as previously reported. 22 Serotonin release during platelet adhesion to collagen was 3% (range, 1% to 4%) and to clot, 30% (range, 23% to 39%).
Preparation of Collagen-Coated Coverslips and Plasma Clots as Adhesive Substrates for Platelets
Before clots were induced, pooled, citrated plasma was first diluted 1:2 in PBS (Life Technologies). Plasma (100 L per coverslip) clots were generated with calcium (5 mmol/L CaCl 2 ) and thrombin (0.1 U per coverslip) on round, plastic Thermanox coverslips (area 1.77 cm 2 ; Nunc), incubated for 30 minutes at 37°C in a humid chamber and for 30 minutes at 22°C, and washed 6 times in PBS. The final concentration of ionized calcium under the conditions of the clot was physiological: 1.1 mmol/L (Microlyte 6, Kone Instruments; reference values, 1.1 to 1.3 mmol/L). Collagen-coated coverslips were prepared from Horm collagen reagent (Nycomed Arzneimittel; 25 g/mL in isotonic glucose solution), incubated (1 hour, 35°C) in a humid chamber, and washed 3 times in PBS. Bovine serum albumin (2% BSA, Sigma) in PBS was used as a control substrate and a blocking agent.
Two-Stage PCA Assay
Phase 1: Platelet Deposition on Adhesive Substrates
GFPs (500 L) in HEPES buffer supplemented with 2 mmol/L CaCl 2 and 1 mmol/L MgCl 2 were first allowed to adhere to the substrate-coated coverslips in 24-well, flat-bottomed multidish plates (Nunc) blocked with BSA. The samples were incubated (37°C, 30 minutes) under slow rotation (70 rpm) and washed 3 times in PBS. Buffer without platelets served as a control. Adhesive surfaces, prepared as previously described, 23 were studied by scanning electron microscopy (JEOL model 820). F1ϩ2 was measured to estimate adhesion-induced soluble thrombin generation. The samples (9 volumes) were collected in 1 volume of 35 mmol/L citric acid, 75 mmol/L sodium citrate, 0.14 mol/L dextrose, 6 mmol/L EDTA, 5 mmol/L adenosine, 25 U/mL hirudin, and 25 U/mL heparin (1 volume) 24 and centrifuged (11 000g, 5 minutes, 4°C). F1ϩ2 was measured from the supernatant.
Phase 2: Generation of Soluble Thrombin on Adherent Platelets
PCA was initiated on adherent platelets by incubating (37°C, under slow rotation) pooled, defibrinated plasma (1:20 dilution in PBS with Ca 2ϩ [0.9 mmol/L] and Mg 2ϩ [0.76 mmol/L]; 500 L) with or without tissue thromboplastin (1:5000 final concentration of Thromborel S, Behringwerke AG). The time dependence of plateletinduced thrombin generation after adhesion to collagen or clot was estimated during incubation periods ranging between 2 and 30 minutes in the procoagulation assay.
Thrombin generation was stopped by diluting the supernatant to an equal volume with a stopping buffer (125 mmol/L NaCl, 50 mmol/L Tris-HCl, and 2 mmol/L EDTA; pH 7.9). 13 Twenty microliters of chromogenic substrate S-2238 (4.7 mmol/L, Chromogenix AB) was added to 180 L of the diluted sample and incubated for 6 minutes; the reaction was terminated by addition of 20% acetic acid (50 L), and absorbance was measured at 405 nm by a Labsystems Multiscan MCC (Labsystems). Duplicate samples were assayed, and the amount (in units per milliliter) of thrombin was estimated with a standard curve of ␣-thrombin (Dade).
PCA of Permanently Adhered Platelets in Comparison With PCA of Platelets Activated in Suspension
The PCA of adherent platelets was compared with that of GFPs in suspension at the same platelet amount that had adhered, after activation with 10 mol/L SFLLRN (Bachem, Bubendorf) and 10 g/mL collagen, or with 10 mol/L calcium ionophore A23187 (Sigma). Platelets were first activated either by a collagen surface or by the soluble agonists under slow rotation (30 minutes, 37°C). Four hundred sixty-five microliters of this platelet suspension was incubated with 25 L of defibrinated plasma and 10 L of 1:100-diluted Thromborel S for 15 minutes. Samples were diluted in stopping buffer and centrifuged (11 000g, 5 minutes, 22°C) to discharge the platelets, and thrombin generation was measured.
One-Stage PCA Assay: Generation of Soluble Thrombin on PRP Clots
The procoagulant effect of platelets was also studied in a 1-stage assay with PRP clots. PRP was separated after centrifugation (180g, 12 minutes, 22°C), and PPP was centrifuged twice from PRP (1500g, 10 minutes). PRP was adjusted to a density of 200ϫ10 6 platelets per milliliter with PPP and diluted 1:2 in PBS. PRP clots (100 L, corresponding to a final number of 10ϫ10 6 platelets) were prepared on a coverslip by recalcification (15 mmol/l CaCl 2 ) and addition of 0.1 U ␣-thrombin. The PRP clots and their PPP controls were incubated at 37°C for 15 minutes and washed 3 times in PBS. The coverslips were incubated for 15 minutes under slow rotation with 1:20-diluted, defibrinated plasma and traces of thromboplastin (37°C, 10 minutes). The clots were also incubated with PBS buffer to estimate the amount of clot-derived soluble thrombin. These absorbance values were subtracted from the results obtained with plasma.
Generation and Contribution of Platelet-Derived MPs
MP generation during adhesion-induced platelet activation was studied in GFP supernatants after the first phase of the assay. GFPs (100ϫ10 6 /mL in HEPES buffer) or buffer control first adhered onto BSA, collagen, or clot for 30 minutes in the presence of 2 mmol/L CaCl 2 and 1 mmol/L MgCl 2 . Nonadherent platelets were centrifuged in the presence of platelet-inhibitory anticoagulant, 24 and tissue factor-triggered PCA of the supernatant (465 L) was studied 10 minutes after the addition of defibrinated plasma (25 L) and 1:100-diluted Thromborel S (10 L). To study the role of soluble platelet-derived MPs after adhesion-induced platelet activation, the PCA of the supernatant was measured both in the presence of MP and after their filtration (0.1-m filter, Millipore). Furthermore, the PCA of the MP supernatant was adjusted with the amount of originally adhered platelets (on collagen or clot) from which the MPs were generated.
Statistical Analysis
N refers to number of donors. The experiments were performed in duplicate or triplicate. Data were expressed as meanϮSD unless indicated otherwise. Student's t test was used for comparison of 2 groups of data.
Results
Determination of Thrombin Generation in Plasma
Generation of soluble thrombin during the PCA assay was estimated by adding known amounts of ␣-thrombin to undiluted or 1:20-diluted, defibrinated plasma or to PBS buffer ( Figure 1 ). Absorbance values due to exogenous thrombin in 1:20-diluted, defibrinated plasma were equal to those in the buffer control. However, in undiluted, defibrinated plasma, absorbance values were markedly lower, reflecting the role of natural anticoagulants in plasma. Loss of thrombin to the forming clot during the procoagulation assay was studied by comparing 1:20-diluted, citrated plasma with the same 1:20diluted, plasma after its defibrination. Absorbances due to soluble thrombin activity at 10 minutes were, on average, 28% (range, 14% to 53%) lower in citrated plasma. To avoid uncontrolled binding of thrombin to forming fibrin during the PCA assay, 1:20-diluted, defibrinated plasma was chosen as the source of coagulation factors.
Plasma PCA on Platelets Adherent to Collagen or Plasma Clot
Next, we determined the time scale of thrombin generation, ranging between 2 and 30 minutes, in 1:20-diluted, defi-brinated plasma on the adhered platelets (Figures 2A and 2B) . The rate at which thrombin was generated by platelets adherent to the clot was significantly greater than that generated by platelets bound to collagen. After initial activation over the clots, thromboplastin did not improve the maximal rate or extent of thrombin generation. In contrast, collagen-induced thrombin generation progressed slowly, reaching a maximum after 20 minutes, but thromboplastin significantly accelerated it.
At 10 minutes, adhered platelets increased the generation of soluble thrombin Ͼ2-fold on the 2 thrombogenic surfaces. The collagen-bound platelets alone did not generate significant amounts of thrombin, whereas in the presence of thromboplastin, collagen enhanced PCA almost 4-fold (1.1Ϯ0.5 vs 0.3Ϯ0.1 U/mL, nϭ3, PϽ0.05). In contrast to collagen, PCA on clot-bound platelets did not benefit further from thromboplastin at 10 minutes (1.8Ϯ0.5 vs 1.5Ϯ0.3 U/mL, nϭ3).
In addition to adhered platelets on a clot surface, we studied the PCA of PRP clots in a 1-stage procoagulation assay. As in the 2-stage assay of PCA on clot-adherent platelets (3.6Ϯ0.8ϫ10 6 platelets on the clot surface), PCA induced by PRP clots with 10ϫ10 6 platelets (0.4Ϯ0.1 U) increased thrombin generation by 2.3-fold when compared with PPP clots (Pϭ0.03).
Direct Coagulation Activity of the Substrates Without and With Adherent Platelets
To further assess the extent of soluble thrombin generation, we measured F1ϩ2 in a suspension of GFPs (100ϫ10 6 /mL) or HEPES buffer after 30 minutes of adhesion (the Table) . Soluble F1ϩ2 in the buffer or on GFPs incubated over collagen did not differ from that obtained over BSA. After incubation of the buffer with thrombin-induced clot, F1ϩ2 reflected minor thrombin generation on the clot surface or release of soluble F1ϩ2, although the clots had been carefully washed. We detected a 15-fold increase in the amount of F1ϩ2 in the supernatant of GFPs. This difference demonstrates thrombin generation induced by the clot-adherent platelets: 26.7 nmol/L F1ϩ2 was supported by Ϸ3.6ϫ10 6 adherent platelets (vide infra).
Effect of Platelet Density on Deposition to Collagen or Plasma Clot and on Subsequent PCA
The specific aim here was to dissociate the effects of platelet adhesion vs their aggregation. To study the effect of platelet density on the extent of their deposition on the thrombogenic surfaces, GFPs (300ϫ10 6 /mL in HEPES buffer) were first labeled with [ 3 H]serotonin (10 nmol/L) and thereafter adjusted to suspensions having different platelet counts (10 to 300ϫ10 6 /mL). At platelet densities Յ100ϫ10 6 /mL, mainly single adherent platelets were visualized on the thrombogenic surfaces, whereas the higher platelet densities supported aggregation on the initial adherent platelets (see Figures 3 and 4) .
Individual deposition of platelets from 6 healthy donors is illustrated in Figures 3A and 3B . At a density of 100ϫ10 6 / mL, platelet deposition on the plasma clot was 3 times that on collagen. However, with platelet densities up to 100ϫ10 6 /mL, only minor interindividual differences in deposition occurred on both substrates, but higher densities had increased variability. This individual variation in platelet deposition was triggered mainly by varying aggregation, especially with clots. The platelet counts of the supernatants after deposition to collagen or clot ( Figures 3C and 3D , respectively) were diminished owing to platelet aggregation. The effect of platelet density on deposition to collagen or clot is also demonstrated in scanning electron photomicrographs (Figures 4A through 4D ). GFPs at 100ϫ10 6 /mL formed an adhesive layer on collagen, showing a fully spread "fried egg" form ( Figure 4A ), whereas at a higher density (300ϫ10 6 /mL), extensive platelet aggregation was triggered on the initial adherent layer ( Figure 4B ). Also, on clots, single platelets adhered with pseudopod extensions at a lower platelet density, but they strongly aggregated at a higher density (Figures 4C and 4D) .
The individual PCAs initiated on these same adherent platelets (without the [ 3 H]serotonin label) by 1:20-diluted, pooled, defibrinated plasma with thromboplastin are presented in Figures 5A and 5B . Although platelet deposition on collagen and clots did not markedly vary with platelet densities up to 100ϫ10 6 /mL ( Figures 3A and 3B) , thrombin generation induced by these adhered platelets (1.2Ϯ0.3ϫ10 6 on collagen and 3.6Ϯ0.8ϫ10 6 on clot) did vary Ͼ3-fold.
These adhesion and procoagulation data were used to adjust platelet-induced thrombin generation to the number of surface-adhered platelets ( Figure 5C ). The platelet adhesion-
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quantified PCA (measured as soluble thrombin) was Ϸ5-fold greater on collagen than on clots (PϽ0.05), and it became attenuated with increasing platelet densities, suggesting the importance of the initial adherent layer.
PCA of Adhesion-Activated Platelets in Comparison With That of Platelets Activated in Suspension
The effect of permanent surface adhesion on platelet PCA was then compared with that of activated GFPs in suspension at the same platelet number that had adhered to collagen ( Figure 6 ). When adjusted to platelet number, collagenadherent platelets supported 30% more thrombin generation than did the same number of strongly activated platelets in suspension. Thus, even when GFPs in suspension were maximally activated with SFLLRN and collagen or with calcium ionophore, their PCAs at 15 minutes still remained markedly lower than that induced by an equal amount of adhesion-activated platelets on collagen.
Effect of Soluble MPs on Coagulation Activation After Adhesion-Induced Platelet Activation
Formation of MPs during platelet adhesion and the subsequent MP-induced PCA were studied in GFP supernatants after adhesion to collagen or clot, with BSA as a control (Figure 7) . Nonadherent platelets were removed from the supernatant by centrifugation, and the tissue factor-triggered PCA was measured in the presence and after removal of soluble MPs by filtration. On collagen, the thromboplastininduced thrombin generation after MP filtration decreased by 32Ϯ6% (nϭ3). After clot-induced platelet activation, MP filtration reduced the PCA of the supernatant by 43Ϯ14%. When the PCA of the soluble MPs was adjusted to the amount of initially adhered platelets on collagen or clot, MP-induced thrombin generation per 10 6 adhered platelets on collagen was Ͼ3-fold that on clot (Pϭ0.01).
Discussion
It is now well established that platelets and clotting factors have several interactive roles in hemostasis and thrombosis. Previous procoagulant studies mainly used soluble platelets in PRP or whole blood. [25] [26] [27] In earlier adhesion-type studies, isolated platelets were first allowed to interact with collagen and then resuspended to react with purified coagulation factors. 13 Our study design provided activation of platelets by their firm adhesion, with subsequent in situ procoagulant membrane alteration. We observed a Ͼ3-fold individual variability in adhesion-induced PCA at a given level of platelet adhesion, independent of the adhesive surface. Importantly, locally adhered and activated platelets had markedly enhanced procoagulant capacity in comparison with platelet suspensions, even on strong activation. This could well be due to enhanced calcium signaling by adhesioninduced activation of the spread platelets and their larger membrane accessibility for coagulation factors, as we have reported earlier. 13 Platelet deposition during phase 1 of the assay was studied both with a radiolabel and by scanning electron microscopy. At 100ϫ10 6 /mL, platelet deposition on plasma clot was 3-fold greater compared with that on collagen, but the . GFPs at different concentrations (10 to 300ϫ10 6 /mL) first adhered to collagen or clot, and PCA in 1:20diluted, pooled, defibrinated plasma with thromboplastin was determined at 10 minutes. Individual symbols correspond with those of Figure 3 . Absorbances (Abs) due to thrombin generation induced by collagen or clot in the absence of platelets were subtracted. The assay was performed in duplicate, and each donor (nϭ6) is depicted separately. PCA was adjusted to the number of deposited platelets on the thrombogenic surface (U/10 6 platelets) and is expressed as meanϮSD for collagen ([diaf] ) and clot ([squlf]) (C). **PϽ0.001, *PϽ0.05. 
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individual variation in deposition on both surfaces was relatively modest in the presence of cations. At higher platelet densities, however, platelet deposition on collagen or clot markedly (2-to 4-fold) varied between donors. Aggregation of GFPs during the first step of the assay reflected activation, because in the absence of plasma, it was mediated by platelet-derived ligands: fibrinogen, von Willebrand factor, or thrombospondin. Instead of using purified clotting factors, we chose to use defibrinated plasma as a source of procoagulants to (1) eliminate uncontrolled loss of the forming thrombin on fibrin and (2) overcome the natural anticoagulants. In the presence of fibrin(ogen) under identical conditions, measurable soluble thrombin was, on average, 28% lower owing to clot formation. The report by Kumar et al 20 also indicated that Ϸ30% of all thrombin formed during coagulation activation is adsorbed onto fibrin. Thrombin generation during PCA was quantified with a thrombin standard. In undiluted plasma, anticoagulants fully blocked the chromogenic action of added thrombin. Plasma dilution of 1:20 seemed to provide enough coagulation factors to overcome natural anticoagulant activity in the PCA assay. Compatible with the idea that the diluted coagulation factors did not become rate limiting during the assay, we observed that collagen-adherent platelets at prolonged incubation and clot-bound platelets at higher densities continued to increase their PCA in this 1:20 plasma dilution. In addition to the use of defibrinated and diluted plasma, the limitations of our study include the absence of flow conditions and other blood cells.
The importance of permanent adhesion on platelet PCA became evident when it was compared with that of platelets in suspension. Because the PCA of adherent platelets clearly exceeded that of the strongly activated platelets in suspension, it is evident that adhesion-and activation-related platelet receptors have a significant impact on PCA. The rate of thrombin generation induced by clot-adherent platelets was markedly faster than that on collagen-adherent platelets during the initial phase of coagulation activation, already reaching a plateau at 10 minutes, and probably due to clot-bound thrombin and MPs. As previously reported, 13 on collagen-adherent platelets, PCA proceeded slowly in the absence of thromboplastin, compatible with the idea that although tissue factor is not absolutely necessary, it induces a local, rapid thrombin "burst" at the site of vascular injury. In experiments with isolated platelets and purified coagulation factors, thrombin generation was prolonged for 15 minutes in the absence of tissue factor. 28 Endothelial injury simultaneously exposes collagen and tissue factor, an integral membrane protein of subendothelial cells, and tissue factor is also carried by monocytes. 29 When the clot has already formed, it contains thrombin and additional procoagulant factors, so that the role of tissue factor is less crucial. However, when PCA at 10 minutes was adjusted with adhesion, the collagenadherent platelets in the presence of thromboplastin generated up to 5 times as much soluble thrombin as did the clotadherent platelets. This surface-associated discrepancy may be related to the retention of forming thrombin on the clot. In addition, this relative platelet-adjusted PCA decreased at increased platelet densities, supporting the importance of the PCA of the first adhesive layer of platelets, with restriction on excessive platelet accumulation. 30 -33 Activation of platelets by their firm adhesion to collagen or plasma clot was accompanied by formation of soluble procoagulant MPs. When MP-derived thrombin generation was adjusted to the number of adherent platelets from which the MPs originated, soluble PCA induced by collagen exceeded that of the clot. This finding is explained by the quantity and/or quality of the MPs produced by the collagen-adherent platelets. Also, as we have shown earlier, platelet-derived MPs bind to fibrin 23 ; the retained MPs may contribute to the rapid initial burst of PCA on the clot while fewer MPs are detected in the supernatant. These findings demonstrate the major differences between collagen and clot as adhesive and thrombogenic surfaces. First, the initial activation of platelets by adhesion to subendothelial collagen leads (in the presence of tissue factor) to a marked burst of thrombin and plateletderived MPs into the circulation. Second, the subsequently forming clot, though contributing to explosive platelet adhesion and PCA as well, seems to retain significant amounts of thrombin and MPs, thus localizing the process at the site of vascular injury. 
